Last Updated : March 29, 2021
Details
FilesGeneric Name:
fremanezumab
Project Status:
Complete
Therapeutic Area:
migraine
Manufacturer:
Teva Canada Innovation
Call for patient/clinician input open:
Brand Name:
Ajovy
Project Line:
Reimbursement Review
Project Number:
SR0641-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
Achieved
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
For the prevention of migraine in adults who have at least 4 migraine days per month.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Indicated for the prevention of migraine in adults who have at least 4 migraine days per month.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of Canada's Drug Agency. Reimbursement criteria from Canada's Drug Agency will be documented in the final recommendation, if applicable.
Key Milestones2 | |
|---|---|
| Call for patient input open | March 30, 2020 |
| Call for patient input closed | May 20, 2020 |
| Clarification: - Patient input submission received from Migraine Canada and Migraine Quebec | |
| Submission received | June 03, 2020 |
| Submission accepted | September 22, 2020 |
| Clarification: - Submission was not accepted for review on 17 June 2020 | |
| Review initiated | September 23, 2020 |
| Draft CADTH review report(s) provided to sponsor for comment | December 18, 2020 |
| Deadline for sponsors comments | January 06, 2021 |
| CADTH responses on draft review report(s) provided to sponsor | February 04, 2021 |
| CADTH review report(s) and responses to comments provided to sponsor | February 04, 2021 |
| Expert committee meeting (initial) | February 17, 2021 |
| Draft recommendation issued to sponsor | March 03, 2021 |
| End of embargo period | March 17, 2021 |
| Final recommendation issued to sponsor and drug plans | March 24, 2021 |
| Final recommendation posted | March 26, 2021 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | April 08, 2021 |
| CADTH review report(s) posted | May 28, 2021 |
Files
Last Updated : March 29, 2021